Heart Failure with Preserved Ejection Fraction: A Therapeutic Brick Wall

In this webinar, Dr. Jon Plehn, MD, vice president of Cardiovascular Medicine at Covance will be joined by Dr. Sanjiv Shah, Professor of Medicine and Director of the T1 Center for Cardiovascular Therapeutics, Northwestern University Feinberg School of Medicine to present the pathophysiologies of HFpEF, history of therapeutic trials and suggest targeted approaches that are likely to better secure therapeutic success in drug development. The two experts will review the possible causes of unrelenting failure in HFpEF drug development and suggest new approaches more likely to garner success.